Articles matching the ‘screening’ Category

July 28th, 2022

Podcast 297: Forget about all that vitamin D testing!!

A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. THE USUAL AUDIO FILE IS AVAILABLE BELOW Steven Cummings has co-written a take-no-prisoners editorial in the New England Journal of Medicine. The topic? Vitamin D supplements. The conclusion? “…providers should stop screening for 25-hydroxyvitamin D levels or recommending vitamin D supplements, and people should stop taking vitamin D […]


July 6th, 2022

Podcast 295: How should clinicians manage severe (but asymptomatic) carotid artery stenosis while awaiting CREST-2’s results?

CREST-2’s results are probably more than a year away. In the meantime, what to do about diagnosed severe (but asymptomatic) carotid stenosis? Recent results suggest that medical management compares favorably with the surgical approach. In this edition, we address the question with a conversation between Dr. Allan Brett, NEJM Journal Watch‘s editor-in-chief, and Dr. Seemant Chaturvedi, […]


March 28th, 2018

Podcast 219: Digital rectal exams shouldn’t be routine in primary care

There simply isn’t enough evidence to sustain its continued use in asymptomatic men, argues our guest. Dr. Jason Profetto, senior author on an Annals of Family Medicine meta-analysis.   Links: Annals of Family Medicine abstract Physician’s First Watch coverage


February 21st, 2018

Podcast 216: What role for MRI in breast cancer screening?

A recent paper in JAMA Internal Medicine sought to examine what happens after breast cancer screening with magnetic resonance imaging. It reported that core and surgical biopsy rates doubled, compared with mammography, in women with a personal history of breast cancer; they rose fivefold among women with no personal breast cancer histories. Dr. Diana Buist, the […]


March 25th, 2016

Podcast 200: Sorting out the results of breast biopsy

Most of the time, pathologists agree with each other about breast biopsy results — especially when the biopsy is negative or indicates invasive cancer. However, the biopsies that fall between those two extremes — that is, atypia and ductal carcinoma in situ — make for tough conversations with patients. This week’s guest, Alexander Borowsky, has written […]


November 21st, 2015

Podcast 191: The prostate screening conundrum

[Running time: 13 minutes] The 2008 and 2012 recommendations from the USPSTF regarding PSA-based prostate screening have been accompanied by drops in both the screening and detection rates of prostate cancer, two studies in JAMA find. Our guest, Dr. David Penson, wrote an editorial accompanying those studies. It attempts to put these new findings into perspective and […]


Clinical Conversations

About the Podcast

Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.

Follow us:
Follow on Apple Podcasts

Follow on Google Podcasts